Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 503

Results For "MED"

6253 News Found

Lupin to acquire supplements portfolio of Anglo-French Drugs & Industries for Rs 325 crore
News | January 18, 2022

Lupin to acquire supplements portfolio of Anglo-French Drugs & Industries for Rs 325 crore

The acquisition would enable addition of established brands with high recall amongst healthcare professionals, especially in the vitamins, minerals and supplements category


Philips integrates cloud-based AI and 3D mapping into Zenition
Digitisation | January 18, 2022

Philips integrates cloud-based AI and 3D mapping into Zenition

New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment


TPVI offers a ray of hope for children with Pulmonic Valve disease
Hospitals | January 18, 2022

TPVI offers a ray of hope for children with Pulmonic Valve disease

Extending nonsurgical treatment options for Failing Pulmonic Valve in patients with congenital heart disease using Transcatheter Pulmonary Valve


Solvay awards €300k science prize to Prof Katalin Kariko for research in mRNA technology
News | January 18, 2022

Solvay awards €300k science prize to Prof Katalin Kariko for research in mRNA technology

Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines


Cosette Pharma acquires rights to Daiichi Sankyo’s eight branded products
Biotech | January 18, 2022

Cosette Pharma acquires rights to Daiichi Sankyo’s eight branded products

As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio


BiologyWorks k(now) handheld molecular device 99.1 % accurate to RT-PCR test
Medical Device | January 18, 2022

BiologyWorks k(now) handheld molecular device 99.1 % accurate to RT-PCR test

Results from the BiologyWorks k(now) molecular test were 99.1% in overall percent agreement with the results of the RT-PCR lab tests


We plan to move to other geographies as we expand: Jeya Kumar, Founder and MD, RaphaCure
interviews | January 17, 2022

We plan to move to other geographies as we expand: Jeya Kumar, Founder and MD, RaphaCure

The tele-heath market in India is expected to touch US $ 5.4 billion by 2025 and the adoption of tele-health has accelerated with the onset of Covid-19 in 2020. We caught up with Jeya Kumar, Founder and MD, RaphaCure, a prominent player in this segment and he outlined the opportunities that lie ahead for this segment


Anurag Yadav is the new Chief Executive Officer of IHH Healthcare India
People | January 17, 2022

Anurag Yadav is the new Chief Executive Officer of IHH Healthcare India

Prior to IHH, Anurag held senior leadership roles in Fortis Healthcare and Manipal Health Enterprises.


Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson injection
Drug Approval | January 17, 2022

Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson injection

The company has 47 ANDA's pending approval with the U.S.FDA


Dr Charles Woler is the new Chairman of Sygnature Discovery
People | January 17, 2022

Dr Charles Woler is the new Chairman of Sygnature Discovery

Dr Woler joins Sygnature Discovery after the company received significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co, in 2021